Publications for Magnus Vrethem
Co-author map based on ISI articles 2007-
Publications mentioned in social media 20 times*
Journal Articles
Magnus Vrethem, J Lindh, Martin Tondel, B Persson and Charlotte Dahle IgA antibodies against tissue transglutaminase, endomysium and gliadin in idiopathic polyneuropathy Acta Neurologica Scandinavica, 2013, 127(2), 109-115.
|
Maria Kvarnström, J Ydrefors, Christina Ekerfelt, Magnus Vrethem and Jan Ernerudh Longitudinal interferon-β effects in multiple sclerosis: differential regulation of IL-10 and IL-17A, while no sustained effects on IFN-γ, IL-4 or IL-13 Journal of the Neurological Sciences, 2013, 325(1-2), 79-85.
Fulltext |
H Tedeholm, J Lycke, B Skoog, V Lisovskaja, J Hillert, Charlotte Dahle, J Fagius, S Fredrikson, Anne-Marie Landtblom, C Malmestrom, C Martin, F Piehl, B Runmarker, L Stawiarz, Magnus Vrethem, O Nerman and O Andersen Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs Multiple Sclerosis, 2013, 19(6), 765-774.
|
Magnus Vrethem, Kristina Malmgren and Jonas Lindh A patient with both narcolepsy and multiple sclerosis in association with Pandemrix vaccination Journal of the Neurological Sciences, 2012, 321(1-2), 89-91.
Web of Science® Times Cited: 1 |
Martin Samuelsson, George Gerdin, Karin Öllinger and Magnus Vrethem Taurine and glutathione levels in plasma before and after ECT treatment Psychiatry Research, 2012, 198(1), 53-57.
|
Johan Mellergård, Anders Tisell, Olof Dahlqvist Leinhard, Ida Blystad, Anne-Marie Landtblom, Kaj Blennow, Bob Olsson, Charlotte Dahle, Jan Ernerudh, Peter Lundberg and Magnus Vrethem Association between Change in Normal Appearing White Matter Metabolites and Intrathecal Inflammation in Natalizumab-Treated Multiple Sclerosis PLoS ONE, 2012, 7(9), e44739.
Fulltext |
Barbro H Skogman, Kajsa Glimaker, Maria Nordwall, Magnus Vrethem, Lars Ödkvist and Pia Forsberg Long-term Clinical Outcome After Lyme Neuroborreliosis in Childhood Pediatrics, 2012, 130(2), 262-269.
Web of Science® Times Cited: 1 |
Istvan Gati, Olof Danielsson, Cecilia Gunnarsson, Magnus Vrethem, Bo Häggqvist, Bengt-Arne Fredriksson and Anne-Marie Landtblom Letter: Bent Spine Syndrome: A Phenotype of Dysferlinopathy or a Symptomatic DYSF Gene Mutation Carrier European Neurology, 2012, 67(5), 300-302.
|
Magnus Vrethem, Maria Kvarnström, J Stenstam, Petra Cassel, M Gustafsson, Anne-Marie Landtblom and Jan Ernerudh Cytokine mapping in cerebrospinal fluid and blood in multiple sclerosis patients without oligoclonal bands Multiple Sclerosis, 2012, 18(5), 669-673.
Web of Science® Times Cited: 2 |
Magnus Vrethem, Charlotte Dahle and Björn Lindvall Subacute neuronopathy in a young man: a possible association with tetracycline treatment Neurology international, 2011, 3(3), e16.
|
Magnus Vrethem, Mona Widhe, Jan Ernerudh, Ulf Garpmo and Pia Forsberg Clinical, diagnostic and immunological characteristics of patients with possible neuroborreliosis without intrathecal Ig-synthesis against Borrelia antigen in the cerebrospinal fluid Neurology International, 2011, 3(1), .
|
Jonas Lindh, Peter Söderkvist, Mats Fredrikson, Shahzad Hosseininia, Martin Tondel, Bodil Persson and Magnus Vrethem Polymorphisms of GSTT1, GSTM1 and EPHX genotypes in patients with cryptogenic polyneuropathy: a case control study Brain and Behavior, 2011, , .
|
Jonas Lindh, Martin Tondel, Bodil Persson and Magnus Vrethem Health-related quality of life in patients with cryptogenic polyneuropathy compared with the general population DISABILITY AND REHABILITATION, 2011, 33(7), 617-623.
|
Martin Gunnarsson, Clas Malmestrom, Markus Axelsson, Peter Sundstrom, Charlotte Dahle, Magnus Vrethem, Tomas Olsson, Fredrik Piehl, Niklas Norgren, Lars Rosengren, Anders Svenningsson and Jan Lycke Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab ANNALS OF NEUROLOGY, 2011, 69(1), 83-89.
Web of Science® Times Cited: 22 |
Måns Edström, Johan Mellergård, Jenny Mjösberg, Maria Jenmalm, Magnus Vrethem, R Press, Charlotte Dahle and Jan Ernerudh Transcriptional characteristics of CD4+ T cells in multiple sclerosis: relative lack of suppressive populations in blood Multiple Sclerosis, 2011, 17(1), 57-66.
Web of Science® Times Cited: 5 |
Magnus Vrethem, N. Reiser, C. Lauermann and Eva Svanborg Polyneuropathy associated with IgM vs IgG monoclonal gammopathy: comparison between clinical and electrophysiological findings Acta Neurologica Scandinavica, 2010, 122(1), 52-57.
Web of Science® Times Cited: 2 |
Jakob Paues and Magnus Vrethem Fatal progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma treated with rituximab Journal of Clinical Virology, 2010, 48(4), 291-293.
Web of Science® Times Cited: 8 |
Johan Mellergård, Måns Edström, Magnus Vrethem, Jan Ernerudh and Charlotte Dahle Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid Multiple Sclerosis, 2010, 16(2), 208-217.
Fulltext Web of Science® Times Cited: 20 |
Gunilla Margareta Liedberg and Magnus Vrethem Polyneuropathy, with and without neurogenic pain, and its impact on daily life activities - a descriptive study Disability and Rehabilitation, 2009, 31(17), 1402-1408.
Web of Science® Times Cited: 4 |
Martin Tondel, Jonas Lindh, Pia Jönsson, Magnus Vrethem and B. Persson Occupational determinants of cryptogenic polyneuropathy Neuroepidemiology, 2006, 26(4), 187-194.
Web of Science® Times Cited: 1 |
Elisabeth Hallin, Johan Mellergård, Magnus Vrethem, Jan Ernerudh and Christina Ekerfelt In vitro Th2 deviation of myelin-specific peripheral blood lymphocytes from patients with multiple sclerosis Journal of Neuroimmunology, 2006, 171( 1-2), 156-162.
Web of Science® Times Cited: 2 |
Jonas Lindh, Martin Tondel, A. Osterberg and Magnus Vrethem Cryptogenic polyneuropathy: Clinical and neurophysiological findings Journal of the peripheral nervous system, 2005, 10(1), 31-37.
Web of Science® Times Cited: 6 |
Magnus Vrethem, Ingrid Fernlund, Jan Ernerudh and Sten Öhman Prognostic value of cerebrospinal fluid IgA and IgG in multiple sclerosis Multiple Sclerosis, 2004, 10(4), 469-471.
Web of Science® Times Cited: 3 |
Christina Ekerfelt, Jan Ernerudh, Pia Forsberg, Anna-Lena Jönsson, Magnus Vrethem, L Ärlehag and Urban Forsum Lyme borreliosis in Sweden - Diagnostic performance of five commercial Borrelia serology kits using sera from well-defined patient groups Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS), 2004, 112(1), 74-78.
Web of Science® Times Cited: 6 |
Mona Widhe, Sara Jarefors, Christina Ekerfelt, Magnus Vrethem, Sven Bergström, Pia Forsberg and Jan Ernerudh Borrelia-specific interferon-γ and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome Journal of Infectious Diseases, 2004, 189(10), 1881-1891.
Web of Science® Times Cited: 37 |
A. Jansson, Jan Ernerudh, Maria Kvarnström, Christina Ekerfelt and Magnus Vrethem Elispot assay detection of cytokine secretion in multiple sclerosis patients treated with interferon-β1a or glatiramer acetate compared with untreated patients Multiple Sclerosis, 2003, 9(5), 440-445.
Web of Science® Times Cited: 12 |
Magnus Vrethem, E Mattsson, H Hebelka, K Leerbeck, A Österberg, Anne-Marie Landtblom, B Balla, H Nilsson, M Hultgren, L Brattström and Bertil Kågedal Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acid Multiple Sclerosis, 2003, 9(3), 239-245.
Web of Science® Times Cited: 28 |
Mona Widhe, Mattias Grusell, Christina Ekerfelt, Magnus Vrethem, Pia Forsberg and Jan Ernerudh Cytokines in Lyme borreliosis: lack of early tumour necrosis factor-α and transforming growth factor-β1 responses are associated with chronic neuroborreliosis Immunology, 2002, 107(1), 46-55.
Web of Science® Times Cited: 22 |
Magnus Vrethem, L Hellblom, M Widlund, M Ahl, O Danielsson, Jan Ernerudh and Pia Forsberg Chronic symptoms are common in patients with neuroborreliosis - A questionnaire follow-up study Acta Neurologica Scandinavica, 2002, 106(4), 205-208.
Web of Science® Times Cited: 35 |
Maria Kvarnström, E. Sidorova, Joakim Nilsson, Christina Ekerfelt, Magnus Vrethem, O. Söderberg, Malin Johansson, Anders Rosén and Jan Ernerudh Myelin protein P0-specific IgM producing monoclonal B cell lines were established from polyneuropathy patients with monoclonal gammopathy of undetermined significance (MGUS) Clinical and Experimental Immunology, 2002, 127(2), 255-262.
Web of Science® Times Cited: 5 |
Magnus Vrethem, Jörgen Boivie, Hans Arnqvist, Helen Holmgren and Torbjörn Lindström Painful polyneuropathy in patients with and without diabetes: Clinical, neurophysiologic, and quantitative sensory characteristics The Clinical Journal of Pain, 2002, 18(2), 122-127.
Web of Science® Times Cited: 11 |
Q Cheng, GX Jiang, S Fredrikson, H Link, J de Pedro-Cuesta and Magnus Vrethem Epidemiological surveillance of Guillain-Barré syndrome in Sweden, 1996-1997. Acta Neurologica Scandinavica, 2000, 101, 104-111.
|
Q. Cheng, GX Jiang, S Fredrikson, H Link, J de Pedro-Cuesta and Magnus Vrethem Incidence of Guillain-Barré syndrome in Sweden 1996. European Journal of Neurology, 2000, 7, 11-16.
|
Q. Cheng, GX Jiang, R. Press, M. Andersson, B. Ekstedt and Magnus Vrethem Clinical epidemiology of Guillain-Barre syndrome in Sweden 1996-1997: a prospective study. European Journal of Neurology, 2000, 7, 685-692.
|
Thomas Masterman, Arturs Ligers, Olle Olerup, Magnus Vrethem and Jan Hillert CTLA-4 dimorphisms in gammopathyassociateperipheral neuropathy. European Journal of Neurology, 1999, 6, 491-493.
|
G Solders, I Nennesmo, Jan Ernerudh, M Cruz and Magnus Vrethem Lymphocytes in sural nerve biopsies from patients with plasma cell dyscrasia and polyneuropathy. Journal of the peripheral nervous system, 1999, 4, 91-98.
|
RA Elkarim, M Mustafa, H Link, M Bakhiet, Christina Ekerfelt, Magnus Vrethem and Jan Ernerudh Induction of neutralizing autoantibodies to interferon-gamma in patients with polyneuropathy. Human Antibodies, 1999, 9, 55-60.
|
Charlotte Dahle, Christina Ekerfelt, Magnus Vrethem, Margareta Samuelsson and Jan Ernerudh T helper type 2 like cytokine responses to peptides from P0 and P2 myelin proteins during the recovery phase of Guillain-Barré syndrome Journal of the Neurological Sciences, 1997, 153(1), 54-60.
|
Charlotte Dahle, Magnus Vrethem and Jan Ernerudh T lymphocyte subset abnormalities in peripheral blood from patients with the Guillain-Barré syndrome Journal of Neuroimmunology, 1994, 53(2), 219-225.
|
Conference Articles
Anders Tisell, Johan Mellergård, Olof Dahlqvist Leinhard, Charlotte Dahle, Jan Ernerudh, Magnus Vrethem, Anne-Marie Landtblom and Peter Lundberg Brain Atrophy in MS Patients Correlates with Creatine Concentrations ISMRM 20th Annual Meeting & Exhibition, 5-11 May, 2012, Melbourne, Australia, 2012.
|
Anders Tisell, Johan Mellergård, Olof Dahlqvist Leinhard, Charlotte Dahle, Jan Ernerudh, Magnus Vrethem, Anne-Marie Landtblom and Peter Lundberg Multiple Sclerosis Severity Score (MSSS) Correlates With Changes in NAWM Metabolism During Treatment ESMRMB, Leipzig 2011, 2011.
|
Anders Tisell, Johan Mellergård, Olof Dahlqvist Leinhard, Charlotte Dahle, Jan Ernerudh, Magnus Vrethem, Anne-Marie Landtblom and Peter Lundberg Increased Glia in Multiple Sclerosis Patients Correlates with Intrathecal Inflammation ESMRMB, Leipzig 2011, 2011.
|
Istvan Gati, Olof Danielsson, Magnus Vrethem, Hans Lindehammar, B Lindvall, Bo Häggqvist, Bengt-Arne Fredriksson and Anne-Marie Landtblom SENSORY ATAXIC NEUROPATHY WITH DYSARTHRIA/DYSPHAGIA AND OPHTHALMOPLEGIA (SANDO) - CASE HISTORIES in EUROPEAN JOURNAL OF NEUROLOGY, vol 18, issue SI, pp 282-282 EUROPEAN JOURNAL OF NEUROLOGY, 2011.
|
Martin Tondel, Nicola Murgia, Bodil Persson, Jonas Lindh, Magnus Vrethem and Mats Fredrikson 2,5-Hexanedione in the General Population: Environmental Exposure or Endogenous Production? in EPIDEMIOLOGY, vol 22, issue 1, pp S34-S35 EPIDEMIOLOGY, 2011.
|
Johan Mellergård, Anders Tisell, Olof Dahlqvist Leinhard, Charlotte Dahle, Anne-Marie Landtblom, Jan Ernerudh, Peter Lundberg and Magnus Vrethem MR spectroscopy and quantitative MRI in multiple sclerosis patients treated with natalizumab: changes in normal appearing white matter are associated to intrathecal inflammation and clinical variables ECTRIMS 2010, 13-16 October 2010, Gothenburg, Sweden, 2010.
|
Martin Samuelsson, G. Gerdin and Magnus Vrethem Taurine levels in plasma before and after three ECT treatments in EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol 20, issue , pp S426-S426 EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010.
|
Måns Edström, Charlotte Dahle, Maria Jenmalm, Johan Mellergård, Jenny Mjösberg, Rayomand Press, Magnus Vrethem and Jan Ernerudh Th1/Th2/Th17 and Treg related transcription factors and cytokines in multiple sclerosis JOURNAL OF NEUROIMMUNOLOGY, 2008.
|
Ph.D. Theses
* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.